0001671687-17-000001.txt : 20170118
0001671687-17-000001.hdr.sgml : 20170118
20170118165603
ACCESSION NUMBER: 0001671687-17-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20170118
DATE AS OF CHANGE: 20170118
EFFECTIVENESS DATE: 20170118
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vividion Therapeutics, Inc.
CENTRAL INDEX KEY: 0001671687
IRS NUMBER: 464373293
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-278715
FILM NUMBER: 17533961
BUSINESS ADDRESS:
STREET 1: 230 NASSAU STREET
CITY: PRINCETON
STATE: NJ
ZIP: 08542
BUSINESS PHONE: 6099246452
MAIL ADDRESS:
STREET 1: 230 NASSAU STREET
CITY: PRINCETON
STATE: NJ
ZIP: 08542
D
1
primary_doc.xml
X0707
D
LIVE
0001671687
Vividion Therapeutics, Inc.
230 NASSAU STREET
PRINCETON
NJ
NEW JERSEY
08542
6099246452
DELAWARE
Cardinal LS, Inc.
None
Corporation
true
2013
John
K.
Clarke
c/o Cardinal Partners, 230 Nassau Street
Princeton
NJ
NEW JERSEY
08542
Executive Officer
Director
John
Park
c/o Cardinal Partners, 230 Nassau Street
Princeton
NJ
NEW JERSEY
08542
Executive Officer
Benjamin
Cravatt
c/o Cardinal Partners, 230 Nassau Street
Princeton
NJ
NEW JERSEY
08542
Director
Biotechnology
Decline to Disclose
- 06b
false
2017-01-03
true
true
false
0
50500000
20200000
30300000
false
8
0
0
0
false
Vividion Therapeutics, Inc.
/s/John K. Clarke
John K. Clarke
President
2017-01-17